AAAAAA
Results: 1-25/29
Authors:
SAKKINEN PA
CUSHMAN M
PSATY BM
KULLER LH
BAJAJ SP
SABHARWAL AK
BOINEAU R
MACY E
TRACY RP
Citation: Pa. Sakkinen et al., CORRELATES OF ANTITHROMBIN, PROTEIN-C, PROTEIN-S, AND TFPI IN A HEALTHY ELDERLY COHORT, Thrombosis and haemostasis, 80(1), 1998, pp. 134-139
Authors:
BAJAJ MS
BAJAJ SP
Citation: Ms. Bajaj et Sp. Bajaj, TISSUE FACTOR PATHWAY INHIBITOR - POTENTIAL THERAPEUTIC APPLICATIONS, Thrombosis and haemostasis, 78(1), 1997, pp. 471-477
Authors:
MATHUR A
ZHONG DG
SABHARWAL AK
SMITH KJ
BAJAJ SP
Citation: A. Mathur et al., INTERACTION OF FACTOR IXA WITH FACTOR VIIIA - EFFECTS OF PROTEASE DOMAIN CA2-SITE, PROTEOLYSIS IN THE AUTOLYSIS LOOP, PHOSPHOLIPID, AND FACTOR-X( BINDING), The Journal of biological chemistry, 272(37), 1997, pp. 23418-23426
Authors:
SABHARWAL AK
PADMANABHAN K
TULINSKY A
MATHUR A
GORKA J
BAJAJ SP
Citation: Ak. Sabharwal et al., INTERACTION OF CALCIUM WITH NATIVE AND DECARBOXYLATED HUMAN FACTOR-X - EFFECT OF PROTEOLYSIS IN THE AUTOLYSIS LOOP ON CATALYTIC EFFICIENCY AND FACTOR VA BINDING, The Journal of biological chemistry, 272(35), 1997, pp. 22037-22045
Authors:
BAJAJ SP
KURUMBAIL RG
STEGEMAN RA
STEVENS AM
SHIEH HS
GIRARD TJ
STALLINGS WC
Citation: Sp. Bajaj et al., CRYSTAL-STRUCTURE OF THE COMPLEX OF DANSYL-GLU-ARG-CHLOROMETHYL KETONE INHIBITED FACTOR VIIA WITH SOLUBLE TISSUE FACTOR, Blood, 90(10), 1997, pp. 1291-1291
Authors:
SUGAHARA Y
CATALFAMO J
BROOKS M
HITOMI E
BAJAJ SP
KURACHI K
Citation: Y. Sugahara et al., ISOLATION AND CHARACTERIZATION OF CANINE FACTOR-IX, Thrombosis and haemostasis, 75(3), 1996, pp. 450-455
Authors:
SAKKINEN PA
MACY EM
BAJAJ SP
SABHARWAL AK
KULLER LH
PSATY BM
TRACY RP
Citation: Pa. Sakkinen et al., CORRELATES OF TISSUE FACTOR PATHWAY INHIBITOR IN AN ELDERLY COHORT FREE OF PREVALENT CARDIOVASCULAR-DISEASE, Circulation, 94(8), 1996, pp. 832-832
Authors:
MATHUR A
ZHONG DG
SABHARWAL AK
SMITH KJ
BAJAJ SP
Citation: A. Mathur et al., INTERACTION OF FACTOR IXA WITH FACTOR VIIIA - EFFECTS OF PHOSPHOLIPID, FACTOR-X, AND MUTATIONS IN THE CALCIUM-BINDING SITE OF FACTOR IXA PROTEASE DOMAIN, Circulation, 94(8), 1996, pp. 1569-1569
Authors:
BAJAJ MS
SABHARWAL AK
KUPPUSWAMY MN
BAJAJ SP
Citation: Ms. Bajaj et al., SYNTHESIS OF TISSUE FACTOR PATHWAY INHIBITOR BY SERUM STIMULATED FIBROBLASTS, Circulation, 94(8), 1996, pp. 4334-4334
Authors:
SABHARWAL AK
BAJAJ SP
AMERI A
TRICOMI SM
HYERS TM
DAHMS TE
TAYLOR FB
BAJAJ MS
Citation: Ak. Sabharwal et al., TISSUE FACTOR PATHWAY INHIBITOR AND VON-WILLEBRAND-FACTOR ANTIGEN LEVELS IN ADULT-RESPIRATORY-DISTRESS-SYNDROME AND IN A PRIMATE MODEL OF SEPSIS (VOL 151, PG 758, 1995), American journal of respiratory and critical care medicine, 151(6), 1995, pp. 2119-2119
Authors:
SABHARWAL AK
BAJAJ SP
AMERI A
TRICOMI SM
HYERS TM
DAHMS TE
TAYLOR FB
BAJAJ MS
Citation: Ak. Sabharwal et al., TISSUE FACTOR PATHWAY INHIBITOR AND VON-WILLEBRAND-FACTOR ANTIGEN LEVELS IN ADULT-RESPIRATORY-DISTRESS-SYNDROME AND IN A PRIMATE MODEL OF SEPSIS, American journal of respiratory and critical care medicine, 151(3), 1995, pp. 758-767
Authors:
OSTERUD B
BAJAJ MS
BAJAJ SP
Citation: B. Osterud et al., SITES OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) AND TISSUE FACTOR EXPRESSION UNDER PHYSIOLOGICAL AND PATHOLOGICAL CONDITIONS, Thrombosis and haemostasis, 73(5), 1995, pp. 873-875
Authors:
SABHARWAL AK
BIRKTOFT JJ
GORKA J
WILDGOOSE P
PETERSEN LC
BAJAJ SP
Citation: Ak. Sabharwal et al., HIGH-AFFINITY CA2-BINDING SITE IN THE SERINE-PROTEASE DOMAIN OF HUMANFACTOR VIIA AND ITS ROLE IN TISSUE FACTOR-BINDING AND DEVELOPMENT OF CATALYTIC ACTIVITY(), The Journal of biological chemistry, 270(26), 1995, pp. 15523-15530
Authors:
BAJAJ SP
Citation: Sp. Bajaj, A PCR-BASED METHOD FOR SITE-SPECIFIC DOMAIN REPLACEMENT THAT DOES NOTREQUIRE RESTRICTION RECOGNITION SEQUENCES (VOL 15, PG 874, 1993), BioTechniques, 16(5), 1994, pp. 840-840
Authors:
ZHONG DG
SMITH KJ
BIRKTOFT JJ
BAJAJ SP
Citation: Dg. Zhong et al., FIRST EPIDERMAL GROWTH FACTOR-LIKE DOMAIN OF HUMAN BLOOD-COAGULATION FACTOR-IX IS REQUIRED FOR ITS ACTIVATION BY FACTOR VIIA TISSUE FACTOR BUT NOT BY FACTOR XIA, Proceedings of the National Academy of Sciences of the United Statesof America, 91(9), 1994, pp. 3574-3578
Authors:
HAMAGUCHI N
BAJAJ SP
SMITH KJ
STAFFORD DW
Citation: N. Hamaguchi et al., THE ROLE OF AMINO-TERMINAL RESIDUES OF THE HEAVY-CHAIN OF FACTOR IXA IN THE BINDING OF ITS COFACTOR, FACTOR VIIIA, Blood, 84(6), 1994, pp. 1837-1842
Authors:
ZHONG D
SABHARWAL AK
SMITH KJ
BAJAJ SP
Citation: D. Zhong et al., ROLE OF 1ST EPIDERMAL GROWTH-FACTOR (EGF1)-LIKE DOMAIN OF FACTOR-IXA IN FACTOR-X ACTIVATION, Blood, 84(10), 1994, pp. 10000531-10000531
Authors:
ZHONG DG
BAJAJ SP
Citation: Dg. Zhong et Sp. Bajaj, A PCR-BASED METHOD FOR SITE-SPECIFIC DOMAIN REPLACEMENT THAT DOES NOTREQUIRE RESTRICTION RECOGNITION SEQUENCES, BioTechniques, 15(5), 1993, pp. 874
Authors:
ANDERSSEN T
HALVORSEN H
BAJAJ SP
OSTERUD B
Citation: T. Anderssen et al., HUMAN-LEUKOCYTE ELASTASE AND CATHEPSIN-G INACTIVATE FACTOR-VII BY LIMITED PROTEOLYSIS, Thrombosis and haemostasis, 70(3), 1993, pp. 414-417
Authors:
ZHONG D
BAJAJ SP
Citation: D. Zhong et Sp. Bajaj, A POLYMERASE CHAIN REACTION-BASED METHOD FOR SITE-SPECIFIC DOMAIN REPLACEMENT THAT DOES NOT REQUIRE RESTRICTION RECOGNITION SEQUENCES - CONSTRUCTION OF A CHIMERIC FACTOR-IX IN WHICH ITS EGFI DOMAIN IS REPLACEDBY THAT OF PROTEIN-C, Thrombosis and haemostasis, 69(6), 1993, pp. 554-554
Authors:
KUPPUSWAMY MN
BAJAJ SP
Citation: Mn. Kuppuswamy et Sp. Bajaj, REGULATION OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) GENE-EXPRESSION IN A HUMAN HEPATOMA-CELL LINE (HEPG2) BY GATA-2 TRANSCRIPTION FACTOR -ABSENCE OF GATA-2 TRANSCRIPTION FACTOR AND TFPI IN NORMAL HEPATOCYTES, Thrombosis and haemostasis, 69(6), 1993, pp. 574-574
Authors:
ZHONG DG
SMITH KJ
BIRKOFT JJ
BAJAJ SP
Citation: Dg. Zhong et al., 1ST EPIDERMAL GROWTH FACTOR-LIKE DOMAIN OF HUMAN FACTOR-IX IS REQUIRED FOR ITS ACTIVATION BY FACTOR-VIIA TISSUE FACTOR BUT NOT BY FACTOR-XIA, Thrombosis and haemostasis, 69(6), 1993, pp. 957-957
Authors:
KUPPUSWAMY MN
SABHARWAL AK
BIRKTOFT JJ
BAJAJ SP
Citation: Mn. Kuppuswamy et al., MOLECULAR CHARACTERIZATION OF HUMAN FACTOR-VII KANSAS(GK704) - SUBSTITUTION OF GLN100 BY ARG IN ONE ALLELE AND OF ARG304 BY GLN POSSIBLY INTHE OTHER ALLELE, Thrombosis and haemostasis, 69(6), 1993, pp. 1292-1292
Authors:
WERLING RW
ZACHARSKI LR
KISIEL W
BAJAJ SP
MEMOLI VA
ROUSSEAU SM
Citation: Rw. Werling et al., DISTRIBUTION OF TISSUE FACTOR PATHWAY INHIBITOR IN NORMAL AND MALIGNANT HUMAN TISSUES, Thrombosis and haemostasis, 69(4), 1993, pp. 366-369
Authors:
TYSON DR
KUPPUSWAMY MN
BROZE GJ
BAJAJ SP
Citation: Dr. Tyson et al., REVISED DNA-SEQUENCE OF EXON-1 AND 5' FLANKING REGION OF THE HUMAN TISSUE FACTOR PATHWAY INHIBITOR GENE, Thrombosis research, 70(3), 1993, pp. 269-273